Navigation Links
Baxa Corporation Launches New Web Site
Date:1/31/2008

ENGLEWOOD, Colo., Jan. 31 /PRNewswire/ -- Baxa Corporation announces the launch of its new corporate Web site. The site provides a global platform for information exchange, product marketing, public relations, and sales and technical support for health-system pharmacists and nurses, as well as pharmaceutical industry representatives. The site redesign updates the baxa.com infrastructure to support more frequent content updates and the addition of multimedia materials and interactive training tools. The new Baxa site addresses customer feedback on desired site content and was developed to provide a better user experience through increased technical content and more in-depth product specification and demonstration materials.

"By updating the site's functionality and page layouts, the redesign allowed us to improve the user experience. Its new search capabilities and content management make it faster to find and access what our visitors are looking for," notes Marian Robinson, Baxa VP of Marketing. Baxa.com provides a wide variety of complimentary training tools and technical and clinical resources that help users understand regulatory requirements, compliance guidelines and industry trends and best practices. A unique feature of the new Baxa site is its information cart facility, which allows users to 'order' documents on the site then download them to their desktops with just a click.

Baxa Corporation markets and sells medical devices for use in health-system pharmacies and for patient care. Its OEM group provides specialty products for packaging with prescription pharmaceuticals. For more information about Baxa, or to demonstrate the new Web site features, visit http://www.baxa.com

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contact:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

Email: marian.robinson@baxa.com

Maggie Chamberlin Holben, APR

Absolutely Public Relations: 303.984.9801 or 303.669.3558

Email: maggie@absolutelypr.com


'/>"/>
SOURCE Baxa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CuraGen Corporation Receives Notification from NASDAQ
2. Healionics Corporation Completes Series A Financing
3. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
4. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
5. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
6. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
7. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
8. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
9. Pharmos Corporation Completes Initial Closing of Private Placement
10. Pharmos Corporation Announces Board and Management Changes
11. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 12, 2017   Protein Sciences Corporation , ... Flublok Influenza Vaccine ®, announced today that ... good safety results and induced strong neutralizing antibodies ... product is expected to advance into human clinical ... the Institute of Technology in Immunobiologicals of the ...
(Date:1/12/2017)... , ... January 12, 2017 ... ... rapid adoption of Limfinity® Cloud, RURO has enhanced the platform to accommodate ... groups, federated login, rapid data searching, and more. In addition to these ...
(Date:1/11/2017)... ... January 11, 2017 , ... As a ... Peru studying the pathogens that cause malaria and tuberculosis. Seeing firsthand the ravages ... discovery. , Now, as an assistant professor of biology and biotechnology at Worcester ...
(Date:1/11/2017)... Yorba Linda, Ca (PRWEB) , ... January 11, ... ... in the U.S. each year and costing healthcare systems more than $23.7 billion, ... patients while controlling costs. , Among the most common sepsis-causing pathogens are ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... , Dec 16, 2016 Research and ... System Market - Global Forecast to 2021" report to their ... The ... to grow at a CAGR of 14.06% from 2016 to 2021. ... and is projected to reach 854.8 Million by 2021. The growth ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, Inc. ... genomics technology company, announced today that on December 13, ... Department of The Nasdaq Stock Market LLC which acknowledged ... price of WaferGen,s common stock had been at $1.00 ... has regained compliance with Listing Rule 5550(a)(2) of the ...
Breaking Biology News(10 mins):